Roseburia hominis: A novel guilty player in ulcerative colitis pathogenesis?

Gut

Volumn 63, Issue 8, 2014, Pages 1204-1205

  Tilg, Herbert ^a   Danese, Silvio ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL STRAIN; CLINICAL TRIAL (TOPIC); CROHN DISEASE; CYTOKINE PRODUCTION; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE ACTIVITY; DYSBIOSIS; ENVIRONMENTAL FACTOR; ENZYME SYNTHESIS; ESCHERICHIA COLI; FAECALIBACTERIUM PRAUSNITZII; FECES MICROFLORA; FERMENTATION MODEL; FUSOBACTERIUM VARIUM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTESTINE FLORA; LACHNOSPIRACEAE; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; MICROBIAL DIVERSITY; NONHUMAN; NOTE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; RELAPSE; REMISSION; ROSEBURIA HOMINIS; ULCERATIVE COLITIS;

ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; DYSBIOSIS; FECES; FEMALE; GRAM-NEGATIVE ANAEROBIC STRAIGHT, CURVED, AND HELICAL RODS; HUMANS; MALE;

EID: 84904038913     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305799     Document Type: Note

References (11)

1. Parkes M. Evidence from genetics for a role of autophagy and innate immunity in IBD pathogenesis. Dig Dis 2012;30:330-3.
2. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011;365:1713-25.
3. Hart AL, Lammers K, Brigidi P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004;53:1602-9. (Pubitemid 39434103)
4. Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010;139:1844-54..
5. Lepage P, Hasler R, Spehlmann ME, et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011;141:227-36.
6. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008;105:16731-6.
7. Varela E, Manichanh C, Gallart M, et al. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment Pharmacol Ther 2013;38:151-61.
8. Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014;63:1275-83.
9. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341:569-73.
10. Dostal A, Fehlbaum S, Chassard C, et al. Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. FEMS Microbiol Ecol 2013;83:161-75.
11. Rajilic-Stojanovic M, Shanahan F, Guarner F, et al. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis 2013;19:481-8.